Abstract
Sulfonated carbon/silica composites derived from biomaterials viz. glucose, maltose, cellulose, chitosan and starch exhibited high catalytic activity for the one-pot synthesis of Hantzsch 1,4-dihydropyridines under solvent-free conditions, and for one-pot synthesis of 2,4,5-trisubstituted imidazoles and 2-arylbenzimidazoles under liquid phase catalysis. The activity of sulfonated carbon/silica composites derived from starch was found to be superior to other sulfonated carbon/ silica composites. The excellent conversions showed that the catalyst has strong and sufficient acidic sites, which are responsible for its catalytic performance. Moreover, these solid acid catalysts owned the advantages of high selectivity and recyclability.
Keywords: 2-arylben-zimidazoles, hantzsch 1, 4-dihydropyridines, sulfonated carbon/silica composites, solid acid catalysts, 2, 4, 5-trisubstituted imidazoles.
Current Catalysis
Title:Sulfonated Carbon/Silica Composites: Highly Efficient Heterogeneous Catalysts for the One-Pot Synthesis of Hantzsch 1,4-dihydropyridines, 2,4,5-trisubstituted Imidazoles and 2-arylbenzimidazoles
Volume: 3 Issue: 1
Author(s): Princy Gupta and Satya Paul
Affiliation:
Keywords: 2-arylben-zimidazoles, hantzsch 1, 4-dihydropyridines, sulfonated carbon/silica composites, solid acid catalysts, 2, 4, 5-trisubstituted imidazoles.
Abstract: Sulfonated carbon/silica composites derived from biomaterials viz. glucose, maltose, cellulose, chitosan and starch exhibited high catalytic activity for the one-pot synthesis of Hantzsch 1,4-dihydropyridines under solvent-free conditions, and for one-pot synthesis of 2,4,5-trisubstituted imidazoles and 2-arylbenzimidazoles under liquid phase catalysis. The activity of sulfonated carbon/silica composites derived from starch was found to be superior to other sulfonated carbon/ silica composites. The excellent conversions showed that the catalyst has strong and sufficient acidic sites, which are responsible for its catalytic performance. Moreover, these solid acid catalysts owned the advantages of high selectivity and recyclability.
Export Options
About this article
Cite this article as:
Gupta Princy and Paul Satya, Sulfonated Carbon/Silica Composites: Highly Efficient Heterogeneous Catalysts for the One-Pot Synthesis of Hantzsch 1,4-dihydropyridines, 2,4,5-trisubstituted Imidazoles and 2-arylbenzimidazoles, Current Catalysis 2014; 3 (1) . https://dx.doi.org/10.2174/22115447113029990015
DOI https://dx.doi.org/10.2174/22115447113029990015 |
Print ISSN 2211-5447 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5455 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Morpho-Functional Features of In-Vitro Cell Death Induced by Physical Agents
Current Pharmaceutical Design Current and Emerging Therapies in Neuroendocrine Tumors: Impact of Genetic Targets on Clinical Outcomes
Clinical Cancer Drugs New Targeted Therapies for Anaplastic Thyroid Cancer
Anti-Cancer Agents in Medicinal Chemistry Neuronal Nitric Oxide Synthase and Sympathetic Nerve Activity in Neurovascular and Metabolic Systems
Current Neurovascular Research Editorial: Lipoprotein (a), More than Just Cholesterol?
Current Medicinal Chemistry Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer’s Disease Patients?
CNS & Neurological Disorders - Drug Targets Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
Current Protein & Peptide Science Mitochondrial Mutations in Atherosclerosis: New Solutions in Research and Possible Clinical Applications
Current Pharmaceutical Design Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Resveratrol and Lifespan in Model Organisms
Current Medicinal Chemistry Potential Therapeutic Targets for Neurodegenerative Diseases: Lessons Learned from Calorie Restriction
Current Drug Targets Inhibition of PI3K/Akt Signaling: An Emerging Paradigm for Targeted Cancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Signal Transduction in Human Cutaneous Melanoma and Target Drugs
Current Cancer Drug Targets Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Current Pharmaceutical Design Soluble Guanylate Cyclase Stimulators and Activators: Where are We and Where to Go?
Mini-Reviews in Medicinal Chemistry The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis
Current Radiopharmaceuticals Docking and 3D-QSAR Studies of Hydrazone and Triazole Derivatives for Selective Inhibition of GRK2 over ROCK2
Letters in Drug Design & Discovery Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design Roles of miRNA in Cardiovascular Development and Dysfunction
Current Medicinal Chemistry The Acid Sphingomyelinase/Ceramide Pathway: Biomedical Significance and Mechanisms of Regulation
Current Molecular Medicine